2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

Sunday, December 13, 2026
06:00 p.m. - 08:00 p.m.
MCCNO - Hall F
Access, Representation, Population Health, Technology and Procedures, Serologic Tests, Blood Banking, Treatment Considerations, Supportive Care, Biological Therapies, Transfusion, Gene Therapy, Non-Biological Therapies, Opioids, Workforce, Artificial Intelligence (AI), Machine Learning, Clinical Practice (Health Services and Quality), Clinical Guidelines, Health Economics, Patient Safety, Practice Models, Quality Improvement, Quality of Care, Systems-Based Hematology, Telemedicine, Diseases, Hemoglobinopathies, Sickle Cell Disease, Metabolic Disorders, Iron Overload, Research, Clinical Research, Health Outcomes Research, Patient-Reported Outcomes, Real-World Evidence, Registries, Study Population, Human, Adult, Pediatric
PAPER

4364 Standardizing inpatient management of pediatric sickle cell vaso-occlusive crisis to reduce hospital length of stay

Christopher Hahn, MD, Apoorva Jagadish, MD2, Avery Faucette, DO3, Elyssa Farr, DO4, Michael Qureshi, MD5, Bora Candir, MD6, Jennifer A Rothman I, MD7
1 Emory University, Atlanta, Georgia, United States
2 Texas Childrens, Houston, Texas, United States
3 Duke University, Durham, North Carolina, United States
4 Duke University, Durham, North Carolina, United States
5 Duke University, Durham, North Carolina, United States
6 Duke University, Durham, North Carolina, United States
7 Duke University, Durham, North Carolina, United States

Introduction:
Vaso-occlusive crisis (VOC) is the most common cause of hospitalization among patients with sickle cell disease (SCD) and contributes substantially to morbidity and healthcare utilization. Although national guidelines recommend rapid analgesia and multimodal pain management, inpatient practices remain variable. Evidence supporting continuous basal opioid infusions with patient-controlled analgesia (PCA) is limited, while demand-only PCA and standardized multimodal protocols may reduce opioid exposure and hospital length of stay (LOS). We implemented an evidence-aligned inpatient VOC pathway with the goal of reducing mean LOS from 6.2 to 4 days.

Methods:
This quality improvement initiative was conducted on the Pediatric Hematology Service at Duke Children’s Hospital using iterative Plan-Do-Study-Act (PDSA) cycles. Baseline data were collected from February through April 2025. A multidisciplinary team of pediatric hematology providers, residents, Med-Peds hospitalists, psychologists, physical therapists, and social workers developed a standardized inpatient VOC algorithm emphasizing scheduled oral opioids, demand-only PCA dosing, multimodal analgesia, and early functional and psychosocial support. The algorithm was implemented in September 2025, and Cycle 1 data were collected through December 2025. Based on Cycle 1 findings, a standardized rounding checklist was incorporated into the inpatient note template in February 2026 to promote daily reassessment, escalation, and discharge planning. Cycle 2 data were collected through May 2026. Outcomes included mean LOS, algorithm adherence, 30-day readmission, acute chest syndrome (ACS), checklist use, and physical therapy consultation.

Results:
The baseline period included 34 VOC admissions. Mean LOS was 6.2 days and was longer among patients aged ≥12 years than those aged <12 years (6.8 versus 4.8 days). PCA was used in 26 admissions (76%); among older patients receiving PCA, 21 of 24 (88%) received a continuous basal infusion. Eight admissions (24%) occurred within 30 days of a prior discharge, and ACS developed during 7 admissions (21%).

Cycle 1 included 25 admissions. Algorithm adherence was 92% (23/25), but mean LOS increased to 7.16 days. LOS remained substantially longer among patients aged ≥12 years than those aged <12 years (8.21 versus 3.83 days). Patients with high healthcare utilization, defined as >10 acute-care encounters during the preceding 12 months, had a mean LOS of 9.4 days compared with 6.6 days among other patients. Seven admissions (28%) occurred within 30 days of discharge, and ACS developed during 6 admissions (24%).

Cycle 2 included 20 admissions. Mean LOS decreased to 5.72 days, representing a 20% reduction from Cycle 1 and an 8% reduction from baseline. The age-associated LOS difference also narrowed: mean LOS was 5.74 days among patients aged ≥12 years and 5.0 days among those aged <12 years. ACS decreased to 2 admissions (10%), while 5 admissions (25%) occurred within 30 days of discharge. Algorithm adherence decreased to 55% (11/20), and the rounding checklist and physical therapy consultation were each documented during only 2 admissions (10%).

Conclusion:
Implementation and iterative refinement of a standardized inpatient VOC algorithm were associated with an 8% reduction in mean LOS compared with baseline and a 20% reduction compared with Cycle 1. Improvement was most pronounced among patients aged ≥12 years, substantially narrowing the age-related LOS disparity. Thirty-day readmission rates remained below the reported national average of approximately 34%, and ACS decreased from 21% at baseline to 10% during Cycle 2. Although the algorithm was generally incorporated into clinical care, variable adherence and limited checklist use highlight opportunities to improve implementation. Future interventions will focus on patients with high healthcare utilization, continued development of individualized pain plans, and transition of VOC admissions to a dedicated advanced practice provider service to promote greater continuity and consistency of inpatient care.

Christopher Hahn, MD: No relevant conflicts of interest to declare.